Peter Clark
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 24
- Lung Cancer Research Studies 12
- Colorectal Cancer Treatments and Studies 3
- Peptidase Inhibition and Analysis 3
-
- Cancer therapeutics and mechanisms 8
- Co-authors
- M L Slevin (12 shared papers)Sally Stenning (2 shared papers)William Allum (1 shared paper)J Bancewicz (1 shared paper)Ruth E. Langley (1 shared paper)Joachim von Pawel (2 shared papers)P. F. M. Wrigley (5 shared papers)Marc B. Brown (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Cancer Chemotherapy and Pharmacology (4 papers)The Lancet Oncology (3 papers)Blood (2 papers)Journal of Clinical Pathology (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Peter Clark
48 papers receiving 3.7k citations
Peter Clark's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 1.8k
- Hematology 258
- Pulmonary and Respiratory Medicine 680
- Surgery 843
- Epidemiology 606
Countries citing papers authored by Peter Clark
This map shows the geographic impact of Peter Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Clark more than expected).
Fields of papers citing papers by Peter Clark
This network shows the impact of papers produced by Peter Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Clark. The network helps show where Peter Clark may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Clark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer Hit paper breakdown → | 2009 | 727 |
| 2 | Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer Hit paper breakdown → | 1999 | 702 |
| 3 | 1989 | 392 | |
| 4 | 2000 | 230 | |
| 5 | 1987 | 210 | |
| 6 | 2008 | 171 | |
| 7 | 2010 | 168 | |
| 8 | 1989 | 157 | |
| 9 | 1994 | 102 | |
| 10 | 2010 | 102 | |
| 11 | 2003 | 94 | |
| 12 | 1999 | 89 | |
| 13 | 1996 | 80 | |
| 14 | 1999 | 74 | |
| 15 | 1995 | 47 | |
| 16 | The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer. | 1992 | 46 |
| 17 | 1977 | 42 | |
| 18 | Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity. | 1985 | 42 |
| 19 | 1978 | 31 | |
| 20 | 2005 | 31 |
About Peter Clark
Peter Clark is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Surgery, having authored 48 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (12 papers), Cancer therapeutics and mechanisms (8 papers), Neuroendocrine Tumor Research Advances (7 papers), Multiple Myeloma Research and Treatments (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Immunotherapy and Immune Responses (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (1.8k citations), Hematology (258 citations), Pulmonary and Respiratory Medicine (680 citations), Surgery (843 citations) and Epidemiology (606 citations). Peter Clark has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include M L Slevin, Sally Stenning, William Allum, J Bancewicz, Ruth E. Langley, Joachim von Pawel, P. F. M. Wrigley, Marc B. Brown, David J. Potter and Richard J. Osborne. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, The Lancet Oncology, Blood and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.